This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
Will Optum Aid UnitedHealth Group's (UNH) Q3 Earnings?
by Zacks Equity Research
Revenue and earnings gains across all the Optum's subsegments should aid UnitedHealth's Q3 earnings.
Friday Bounce Ends a Volatile Week for Stocks
by David Borun
Interest rates fears fuel the biggest weekly decline in 7 months
UnitedHealth Group (UNH) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $259.41, marking a +0.89% move from the previous day.
Should You Buy UnitedHealth Group (UNH) Ahead of Earnings?
by Zacks Equity Research
UnitedHealth Group (UNH) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
Will UnitedHealth's (UNH) Revenue Growth Aid Q3 Earnings?
by Zacks Equity Research
Revenue growth at the company's Optum and United Healthcare segments should drive earnings in Q3.
UnitedHealth Group (UNH) Q3 Earnings Preview: What to Know Ahead of the Release
by Zacks Equity Research
UnitedHealth (UNH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
WellCare Health, agilon health to Provide Value-Based Care
by Zacks Equity Research
WellCare Health (WCG) purchases agilon health to provide enriched patient care in Texas.
Stocks Take a Breather as Rates Rise
by David Borun
An increase in rates at the back end of the curve spooks investors, but the fundamanentals remain strong.
Molina Healthcare Sells MMS Unit to Streamline Business
by Zacks Equity Research
Molina Healthcare (MOH) sells its Medicaid Solutions unit to focus on core operations.
MEDNAX Buys Radiology Specialists to Expand Business
by Zacks Equity Research
MEDNAX (MD) boosts its radiology business with the acquisition of Radiology Specialists.
WellCare Health's (WCG) Buyout to Expand Medicare Business
by Zacks Equity Research
WellCare Health's (WCG) impending buyout of Aetna's Medicare business to expand and cement its foothold in the rapidly growing market.
UnitedHealth Group (UNH) Stock Moves 0.53%: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed the most recent trading day at $266.04, moving +0.53% from the previous trading session.
4 Health Insurance Stocks Poised for Earnings Beat in Q3
by Sapna Bagaria
Higher enrollment, premium increase, cost management and share buyback should aid health insurers' earnings in the third quarter, partly offset by higher operating costs.
7 Solid Reasons to Add UnitedHealth (UNH) to Your Portfolio (revised)
by Zacks Equity Research
Banking on robust revenues, a bullish 2018 view, strong Optum segment and membership growth, UnitedHealth (UNH) shows great prospects to generate high returns for investors.
7 Solid Reasons to Add UnitedHealth (UNH) to Your Portfolio
by Zacks Equity Research
Banking on robust revenues, a bullish 2018 view, strong Optum segment and membership growth, UnitedHealth (UNH) shows great prospects to generate high returns for investors.
6 Reasons to Invest in WellCare Health for Portfolio Boost
by Zacks Equity Research
Banking on strong financial position, inorganic growth and a solid top-line improvement, WellCare Health (WCG) possesses great potential to generate high returns for investors.
Has UnitedHealth Group (UNH) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (UNH) Outperforming Other Medical Stocks This Year?
UnitedHealth Group (UNH) Gains As Market Dips: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed the most recent trading day at $266.70, moving +0.11% from the previous trading session.
Simon Opens Hotel at Southdale Center, Boosts Redevelopment
by Zacks Equity Research
Simon Property Group's (SPG) addition of Homewood Suites by Hilton Edina Minneapolis to the Southdale Center's mixed-use development comes as part of its densification efforts.
The Zacks Analyst Blog Highlights: UnitedHealth, Adobe, Amgen, UPS and Bayer
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UnitedHealth, Adobe, Amgen, UPS and Bayer
Can UnitedHealth (UNH) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
UnitedHealth (UNH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Top Research Reports for UnitedHealth, Adobe & Amgen
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH), Adobe (ADBE) and Amgen (AMGN).
Dow Within Striking Distance of Record High Level: 4 Picks
by Nalak Das
Despite trade war concerns, a robust U.S. economy and strong earnings results bolstered investors' confidence in the stock markets enabling the Dow to climb out of the rut.
Dow 30 Stock Roundup: Coca-Cola Buys Costa, DowDuPont Earnings Impress
by Swarup Gupta
The index remained weighed down by trade tensions during a holiday-shortened week.
UnitedHealth Group (UNH) Stock Moves -0.28%: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed the most recent trading day at $267.65, moving -0.28% from the previous trading session.